References
- Talotta R, Atzeni F, Bazzichi L, Giacomelli C, Di Franco M, Salaffi F,
Sarzi-Puttini P. Algo-dysfunctional syndromes: a critical digest of
the recent literature. Clin Exp Rheumatol. 2015;33(1Suppl88): S102-8
- Chen X, You J, Ma H, Zhou M, Huang C. Efficacy and safety of
hyperbaric oxygen therapy for fibromyalgia: a systematic review and
meta-analysis. BMJ Open. 2023 Jan 23;13(1): e062322.
- Hampson NB, Ed.: Hyperbaric oxygen therapy: 1999 Committee report.
Kensington MD, Undersea and Hyperbaric Medical Society, 1999.
- Hadanny A, Efrati S. Oxygen-a limiting factor for brain recovery.
Critical Care 2015; 19:307
- Wolfe F, Clauw D J, Fitzcharles M A, Goldenberg D L, Häuser W, Katz R
L, Mease P J, Russell A S, Russell I J, Walitt B. 2016 Revisions to
the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis
and Rheumatism 46 (2016) 319–329
- Alciati A, Nucera V, Masala IF, Giallanza M, La Corte L, Giorgi V,
Sarzi-Puttini P, Atzeni F. One year in review 2021: fibromyalgia. Clin
Exp Reumathol. 2021;39 Suppl 130:3–12.
- Siracusa R, Di Paola R, Cuzzocrea S, Impellizzeri D. Fibromyalgia:
Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int
J Mol Sci. 2021 Apr 9;22(8):3891.
- Wolfe, F.; Ross, K.; Anderson, J.; Russell, I.J.; Hebert, L. The
prevalence and characteristics of fibromyalgia in the general
population. Arthritis Rheum. 1995, 38, 19–28.
- Calandre EP, Navajas-Rojas MA, Ballesteros J, GarciaCarrillo J,
Garcia-Leiva JM, Rico-Villademoros F: Suicidal ideation in patients
with fibromyalgia: A cross-sectional study. Pain Pract 15:168-174,
2015
- Fassbender HG, Wegner K: Morphologie und Pathogenese des
Weichteilrheumatismus. [Morphology and pathogenesis of soft-tissue
rheumatism]. Z Rheumaforsch 1973; 32: 355 – 374
- Katz DL, Greene L, Ali A, Faridi Z. The pain of fibromyalgia syndrome
is due to muscle hypoperfusion induced by regional vasomotor
dysregulation. Med Hypotheses 2007;69(3):517–25.
- Casale R, Sarzi-Puttini P, Botto R, Alciati A, Batticciotto A, Marotto
D, Torta R. Fibromyalgia and the concept of resilience Clin Exp
Rheumatol 2019; 37 (Suppl. 116): S105-13.
- Meeus M, Nijs J: Central sensitization: A biopsychosocial explanation
for chronic widespread pain in patients with fibromyalgia and chronic
fatigue syndrome. Clin Rheumatol 26:465-473, 2007
- Theoharides T C, Tsilioni I, Bawazeer M. Mast cells, neuroinfammation
and pain in fbromyalgia syndrome. Front Cell Neurosci 2019; 13: 353
- Clos-Garcia M, Andrés-Marin N, Fernández-Eulate G, Abecia L, Lavín J
L, van Liempd S, Cabrera D, Félix Royo 8, Alejandro Valero 9, Nerea
Errazquin 10, María Cristina Gómez Vega 11, Leila Govillard 12,
Michael R Tackett 13, Genesis Tejada 14, Esperanza Gónzalez 15, Juan
Anguita 16, Luis Bujanda 17, Ana María Callejo Orcasitas 18, Ana M
Aransay 19, Olga Maíz 20, Adolfo López de Munain 21, Juan Manuel
Falcón-Pérez 22 Gut microbiome and serum metabolome analyses identify
molecular biomarkers and altered glutamate metabolism in fbromyalgia.
EBioMedicine 2019; 46: 499-511.
- Harris R E, Sundgren P C, Craig A D, Kirshenbaum E, Sen A, Napadow V,
et al. Elevated insular glutamate in fibromyalgia is associated with
experimental pain. Arthritis Rheum. 2009;60(10):3146-52
- Foester B R, Petrou M, Edden R A, Sundgren P C, Schmidt-Wilcke T, Lowe
S E et al. Reduced insular gamma-aminobutyric acid in fibromyalgia.
Arthritis Rheum 2012;64(2):579-83.
- P. B. Wood, P. Schweinhardt, E. Jaeger et al., “Fibromyalgia patients
show an abnormal dopamine response to pain,” The European Journal of
Neuroscience, vol. 25, no. 12, pp. 3576– 3582, 2007
- P. Sarchielli, M. Di Filippo, K. Nardi, and P. Calabresi,
“Sensitization, glutamate, and the link between migraine and
fibromyalgia,” Current Pain and Headache Reports, vol. 11, no. 5, pp.
343–351, 2007.
- I. J. Russell, M. D. Orr, B. Littman et al., “Elevated cerebrospinal
fluid levels of substance P in patients with the fibromyalgia
syndrome,” Arthritis and Rheumatism, vol. 37, no. 11, pp. 1593–1601,
1994.
- Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A, Kramer E:
A patient survey of the impact of fibromyalgia and the journey to
diagnosis. BMC Health Serv Res 10:102, 2010
- Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL,
Tugwell P, Campbell SM, Abeles M, Clark P: The American College of
Rheumatology 1990 Criteria for the Classification of Fibromyalgia.
Report of the Multicenter Criteria Committee. Arthritis Rheum
33:160-172, 1990
- Hauser W, Sarzi-Puttini P, Fitzcharles M-A: Fibromyalgia syndrome:
under-, over-and misdiagnosis. Clin Exp Rheumatol 2019; 37 (Suppl.
119): S90-7.
- Undersea and Hyperbaric Medical Society. Indications for hyperbaric
oxygen therapy. https://www.uhms.org/resources/ hbo-indications.html.
- Yildiz S, Kiralp MZ, Akin A, Keskin I, Ay H, Dursun H, Cimsit M. A new
treatment modality for fibromyalgia syndrome: hyperbaric oxygen
therapy. J Int Med Res. 2004 May-Jun;32(3):263-7.
- A. Rus, I. Robles-Fernandez, L. J. Martinez-Gonzalez, R. Carmona, and
M. J. Alvarez-Cubero, “Influence of oxidative stress-related genes on
susceptibility to fibromyalgia,” Nursing Research, vol. 70, no. 1,
pp. 44–50, 2021.
- E. Palzur, M. Zaaroor, E. Vlodavsky, F. Milman, and J. F. Soustiel,
“Neuroprotective effect of hyperbaric oxygen therapy in brain injury
is mediated by preservation of mitochondrial membrane properties,”
Brain Research, vol. 1221, pp. 126– 133, 2008.
- T. Matsunami, Y. Sato, T. Sato, and M. Yukawa, “Antioxidant status
and lipid peroxidation in diabetic rats under hyperbaric oxygen
exposure,” Physiological Research, vol. 59, no. 1, pp. 97–104, 2010.
- Mense S, Stahnke M. Responses in muscle afferent fibres of slow
conduction velocity to contractions and ischaemia in the cat. J
Physiol 1983;342(1):383–97
- Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ. Use of
P-31 magnetic resonance spectroscopy to detect metabolic abnormalities
in muscles of patients with fibromyalgia. Arthritis Rheum
1998;41(3):406–13.
- El-Shewy KM, Kunbaz A, Gad MM, et al. Hyperbaric oxygen and aerobic
exercise in the long-term treatment of fibromyalgia: A narrative
review. Biomed Pharmacother 2019;109:629–38.
- Guggino G, Schinocca C, Lo Pizzo M et al.: T helper 1 response is
correlated with widespread pain, fatigue, sleeping disorders and the
quality of life in patients with fbromyalgia and is modulated by
hyperbaric oxygen therapy. Clin Exp Rheumatol 2019; 37 (Suppl. 116):
S81-9
- A. Hadanny, S. Efrati. The Hyperoxic-Hypoxic Paradox.
Biomolecules 2020 Jun 25;10(6):958.
- Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast
Reconstr Surg. 2011 Jan;127 Suppl 1(Suppl 1):131S-141S
- Evaluation of a Hyperbaric Oxygen Therapy Intervention in Individuals
with Fibromyalgia.
Curtis K, Katz J, Djaiani C, O’Leary G, Uehling J, Carroll J, Santa Mina
D, Clarke H, Gofeld M, Katznelson R.Pain Med. 2021 Jun
4;22(6):1324-1332.
Efrati S, Golan H, Bechor Y, Faran Y, Daphna-Tekoah S, Sekler G,
Fishlev G, Ablin JN, Bergan J, Volkov O, Friedman M, Ben-Jacob E,
Buskila D. Hyperbaric oxygen therapy can diminish fibromyalgia
syndrome–prospective clinical trial. PLoS One. 2015 May
26;10(5):e0127012